Intelligent Bio Solutions (INBS) Payables (2020 - 2024)
Intelligent Bio Solutions has reported Payables over the past 5 years, most recently at $2.5 million for Q1 2024.
- Quarterly results put Payables at $2.5 million for Q1 2024, up 29.1% from a year ago — trailing twelve months through Mar 2024 was $2.5 million (up 29.1% YoY), and the annual figure for FY2023 was $3.0 million, up 82.34%.
- Payables for Q1 2024 was $2.5 million at Intelligent Bio Solutions, up from $2.1 million in the prior quarter.
- Over the last five years, Payables for INBS hit a ceiling of $4.0 million in Q3 2023 and a floor of $448886.0 in Q4 2021.
- Median Payables over the past 5 years was $1.5 million (2021), compared with a mean of $1.7 million.
- Peak annual rise in Payables hit 430.02% in 2022, while the deepest fall reached 41.9% in 2022.
- Intelligent Bio Solutions' Payables stood at $734825.0 in 2020, then plummeted by 38.91% to $448886.0 in 2021, then skyrocketed by 430.02% to $2.4 million in 2022, then dropped by 10.32% to $2.1 million in 2023, then rose by 17.05% to $2.5 million in 2024.
- The last three reported values for Payables were $2.5 million (Q1 2024), $2.1 million (Q4 2023), and $4.0 million (Q3 2023) per Business Quant data.